Quarterly report pursuant to Section 13 or 15(d)

SEGMENT INFORMATION

v3.8.0.1
SEGMENT INFORMATION
3 Months Ended
Mar. 31, 2018
Segment Reporting [Abstract]  
SEGMENT INFORMATION

NOTE 18 – SEGMENT INFORMATION

 

For the three months ended March 31, 2018, the Company operated in three reportable business segments - (1) the real property operating segment, (2) the performing development services for hospitals and sales of related products developed to hospitals segment, and (3) the medical related consulting services segment. For the three months ended March 31, 2017, the Company operated in one reportable business segment – the medical related consulting services segment. The Company’s reportable segments are strategic business units that offer different services and products. They are managed separately based on the fundamental differences in their operations. Information with respect to these reportable business segments for the three months ended March 31, 2018 and 2017 was as follows:

  

    Three Months Ended
March 31, 2018
    Three Months Ended
March 31, 2017
 
Revenues            
Real property operating   $ 296,623     $    
Development services and sales of developed products     11,290          
Medical related consulting services – related party           66,286    
      307,913       66,286    
Depreciation and amortization                  
Real property operating     32,624          
Development services and sales of developed products     86,749          
Medical related consulting services – related party     4,006       26    
      123,379       26    
Interest expense                  
Real property operating     236,986          
Development services and sales of developed products              
Medical related consulting services – related party              
      236,986          
Net loss                  
Real property operating     (237,700 )        
Development services and sales of developed products     (173,474 )        
Medical related consulting services     (100,132 )     (549,333 )  
Other (a)     (1,039,663 )        
    $ (1,550,969 )   $ (549,333 )  

 

Identifiable long-lived tangible assets at March 31, 2018 and December 31, 2017   March 31, 2018     December 31, 2017  
Real property operating   $ 7,612,747     $ 7,645,371  
Development services and sales of developed products     120,396       5,857  
Medical related consulting services     17,224       20,558  
    $ 7,750,367     $ 7,671,786  

 

Identifiable long-lived tangible assets at March 31, 2018 and December 31, 2017   March 31, 2018     December 31, 2017  
United States   $ 7,613,567     $ 7,646,270  
China     136,800       25,516  
    $ 7,750,367     $ 7,671,786  

 

  (a) The Company does not allocate any general and administrative expense of its being a public company activities to its reportable segments as these activities are managed at a corporate level.